Pfizer-BioNTech COVID-19 Vaccine in Gynecologic Oncology Patients: A Prospective Cohort Study.

Innocenza PalaiaGiuseppe Caruso Violante Di Donato Anna Rita VestriAnna NapoliGiorgia PerniolaMatteo CasinelliDanilo Alunni FegatelliRoberta CampagnaFederica TomaoDebora D'AnielloGuido AntonelliLudovico Muzii

Published in: Vaccines (2021)

The COVID-19 vaccine was safe and immunogenic in gynecologic oncology patients under chemotherapy. Serological monitoring and further vaccine shots should be considered to boost protection.

Keyphrases

end stage renal disease
sars cov
chronic kidney disease
newly diagnosed
ejection fraction
peritoneal dialysis
prognostic factors
palliative care
patient reported
locally advanced